Article Text


In vitro toxicology of respirable Montserrat volcanic ash
  1. Martin R Wilsona,
  2. Vicki Stonea,
  3. Richard T Cullenb,
  4. Alison Searlb,
  5. Robert L Maynardc,
  6. Kenneth Donaldsona
  1. aBiomedicine Research Group, School of Life Sciences, Napier University, 10 Colinton Road, Edinburgh EH10 5DT, Scotland, UK, bInstitute of Occupational Medicine, 8 Roxburgh Place, Edinburgh EH8 9SU, Scotland, UK, cDepartment of Health, Skipton House, 80 London Road, London SE1 6LW, UK
  1. Mr M R Wilson, Biomedicine Research Group, School of Life Sciences, Napier University, 10 Colinton Road, Edinburgh EH10 5DT, Scotland, UKm.wilson{at}


OBJECTIVES In July 1995 the Soufriere Hills volcano on the island of Montserrat began to erupt. Preliminary reports showed that the ash contained a substantial respirable component and a large percentage of the toxic silica polymorph, cristobalite. In this study the cytotoxicity of three respirable Montserrat volcanic ash (MVA) samples was investigated: M1 from a single explosive event, M2 accumulated ash predominantly derived from pyroclastic flows, and M3 from a single pyroclastic flow. These were compared with the relatively inert dust TiO2and the known toxic quartz dust, DQ12.

METHODS Surface area of the particles was measured with the Brunauer, Emmet, and Teller (BET) adsorption method and cristobalite content of MVA was determined by x ray diffraction (XRD). After exposure to particles, the metabolic competence of the epithelial cell line A549 was assessed to determine cytotoxic effects. The ability of the particles to induce sheep blood erythrocyte haemolysis was used to assess surface reactivity.

RESULTS Treatment with either MVA, quartz, or titanium dioxide decreased A549 epithelial cell metabolic competence as measured by ability to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). On addition of mannitol, the cytotoxic effect was significantly less with M1, quartz, and TiO2. All MVA samples induced a dose dependent increase in haemolysis, which, although less than the haemolysis induced by quartz, was significantly greater than that induced by TiO2. Addition of mannitol and superoxide dismutase (SOD) significantly reduced the haemolytic activity only of M1, but not M2 or M3, the samples derived from predominantly pyroclastic flow events.

CONCLUSIONS Neither the cristobalite content nor the surface area of the MVA samples correlated with observed in vitro reactivity. A role for reactive oxygen species could only be shown in the cytotoxicity of M1, which was the only sample derived from a purely explosive event. These results suggest that in general the bioreactivity of MVA samples in vitro is low compared with pure quartz, but that the bioreactivity and mechanisms of biological interaction may vary according to the ash source.

Statistics from

The stratovolcano in the Soufriere Hills on the island of Montserrat has been erupting since July 1995 and large amounts of volcanic ash have been generated due to pyroclastic flows, which began in April 1996. The first explosive event was in September 1996 followed by regular explosions from August 1997 until October 1997. A widespread deposition of ash has covered the southern half of the island and analysis of this ash has found it to contain both a substantial respirable component and an unexpectedly large percentage of the toxic silica polymorph cristobalite.1 The crystalline silica content of the fraction of ash less than 10 μm generated by pyroclastic flows formed by lava dome collapse has been reported to be 10%–24% by weight, whereas the fraction of ash less than 10 μm generated by explosive eruptions was 3%–6% by weight.1Volcanic ash is known to exacerbate respiratory symptoms,2-4 and may also pose a risk of pneumoconiosis in heavily exposed populations.5 6 At a week long series of clinics on Montserrat in August 1997, paediatricians attended to more than 50 children a day who had exacerbations of asthma, bronchitis, and irritation of the eyes, ears, nose, and throat due to the volcanic ash.7 Previous studies with ash samples from other volcanoes have, in general, indicated that particle size and the percentage of crystalline free silica both play a crucial part in the development of respiratory diseases such as silicosis and tuberculosis.2 8 In vivo studies have shown that cristobalite is potentially fibrotic9 and may also cause silicosis and cancer.10 The respirable fraction is the fraction of dust that penetrates to the alveolar region and particles that deposit with about 50% in this region are commonly in the range of 3–5 μm in aerodynamic diameter, depending on which convention is used.11 The high respirable fraction and high cristobalite content of the Montserrat volcanic ash (MVA) from the Soufriere Hills volcano indicates that it may present a hazard to human health.1

Preliminary studies have indicated that the ash from pyroclastic flows contains not only a higher percentage of cristobalite, but also a greater amount of respirable particles than ash from explosive events.1

The objectives of the study were:

(1) To investigate the in vitro toxicity of three respirable MVA samples compared with the inert dust TiO2 and the known toxic quartz dust DQ12.

(2)To find the mechanism of any toxicity by the use of inhibitors.

We examined three ash samples: M1 from a single explosive event; M2 a sample of accumulated ash from the first year of activity which was predominantly derived from pyroclastic flows; and M3 from a single pyroclastic flow event.

The effect of these particles on the metabolic competence of the human alveolar type II epithelial cell line A549 was assessed in the presence and absence of the antioxidant mannitol. We also investigated the potential of the particles to induce sheep blood erythrocyte haemolysis as a measure of ability to induce membrane damage. It has been shown that the induction of haemolysis is a useful indicator in measuring the potential cytotoxicity of mineral dusts.12-16 Finally, the mechanism by which the particles induced haemolysis was investigated with antioxidants and a chelator of metal ions.

Materials and methods


The MVA samples studied were derived from three sources. M1 was ash derived from a single explosive event and collected at the Montserrat Volcanic Observatory in Oldtowne in August 1997. M2 was a sample from ash which had accumulated from the beginning of the eruptions to May 1997. This sample was collected in Plymouth from an accumulation depth of 20 cm. M3 was derived from the fallout from a single pyroclastic flow, also collected in 1997.

To remove the coarse dust component, bulk material from each of the ash samples was passed through a 2.5 mm mesh metal sieve. The sieved material was then carried into a cyclone, with a drop out bag attached, by compressed air from which the respirable fraction of the aerosolised ash was collected onto Whatman No 4 filter papers. In all experiments both standard DQ12 quartz17 and fine titanium dioxide (Tioxide, UK: TiO2; 250 nm primary particle diameter) were used as comparative particles.


The specific surface area of the particles was measured with the Brunauer, Emmet and Teller (BET) nitrogen gas adsorption method.18

The cristobalite content of the volcanic ash samples was measured withx ray diffraction (XRD). Samples of each ash were mixed with corundum and the cristobalite contents of each calculated from relative intensity of the cristobalite and corundum peaks in the samples compared with those from calibration standards composed of a mixture of cristobalite, corundum, and an amorphous borate phase.19

Ash samples were prepared for the analysis of distribution of particle size by suspension in filtered water and deposition on polycarbonate filters. Samples of the filters were carbon coated and transferred to copper grids for analysis with a transmission electron microscope (TEM). The particle size distribution of the ash samples and that of the control particles DQ12 and TiO2 was assessed with an image analysis programme.


The human A549 lung epithelial type II cell line20(American Type culture collection) was grown to confluence in Dulbecco's modified Eagle's medium (DMEM; Life Technologies, UK) with 10% heat inactivated foetal calf serum (FCS; Life Technologies, UK), penicillin-streptomycin (0.06 Units/ml and 30 μg/ml respectively; Life Technologies, UK) and L-glutamine (2 mM; Life Technologies, UK). Cultures were incubated in an atmosphere of 5% CO2 at a temperature of 370 C.

Cytotoxicity was assessed by the ability of cells to reduce the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).21 Before exposure to particles, cells were removed from the flask with trypsin and centrifuged at 900g for 2 minutes. The cell pellet was resuspended in DMEM (10% FCS), and the viability was assessed by the ability of cells to exclude 1% trypan blue (Sigma, UK). Cells were then seeded into 96 well plates (Helena Biosciences, UK) at a density of 1×105 cells/ml in DMEM (10% FCS), 200 μl per well and incubated in an atmosphere of 5% CO2 at 370 C for 24 hours.

Suspensions of the MVA samples, DQ12, and TiO2 were made in DMEM (10% FCS) with or without mannitol (Sigma, UK) at a final concentration of 2 mM, which were mixed by brief vortexing followed by sonication for 10 minutes. A series of dilutions of each of the particles were made in DMEM (10% FCS) to give final concentrations ranging from 16.5–1000 μg/ml. The medium was removed from the cells and replaced with either a suspension of particles or fresh DMEM (10% FCS) before incubating at 370 C, 5% CO2 for either 24 or 48 hours.

Immediately after the cells had been treated with particles, MTT (Sigma, UK) was dissolved in DMEM (10% FCS) at 0.5 mg/ml and filter sterilised with a 0.2 μm filter (Whatman, UK). The cell medium and suspensions were then replaced with 200 μl per well of the MTT solution. The cells were incubated with the MTT solution for 4 hours at 370 C, 5% CO2 before removing the medium and replacing with 150 μl of isopropanol/0.04 M HCl (Sigma, UK/ BDH, UK). To prevent interference due to the presence of the particles, the 96 well plates were centrifuged (700 g for 15 minutes) and 100 μl supernatant transferred from each sample to a new 96 well plate to be read at 550 nm (MRX plate reader; Dynatech Labs, UK)


Haemolytic activity of the particles was measured with a 10% erythrocyte solution using a modified method from Razzaboni et al.22 Sheep erythrocytes were obtained from the Scottish Antibody Production Unit (Carluke, UK) and were washed twice in 0.9% sodium chloride solution (Baxter, UK) and centrifuged at 90 g for 5 minutes. The erythrocyte pellets were resuspended and diluted in 0.9% sodium chloride solution to give a 10% erythrocyte preparation. Suspensions of MVA, along with DQ12 and TiO2, were prepared in 0.9% sodium chloride solution, mixed by vortexing and sonicated for 10 minutes. The particle suspensions (150 μl) were mixed in triplicate with 75 μl of 10% erythrocyte preparation. Sodium chloride solution (0.9%) was used as a negative control, and the positive control was 0.1% Triton X-100 (Sigma, UK) in 0.9% sodium chloride solution. The mixtures were incubated at room temperature for 10 minutes on an orbital plate shaker before centrifugation at 700g for 5 minutes. The supernatants (100 μl) from each sample were transferred to a 96 well plate and the optical densities read at 540 nm (MRX plate reader; Dynatech Labs, UK).


To find the possible mechanisms by which the particles induced haemolysis, three antioxidants and an iron chelator were each added to suspensions of MVA, DQ12, and TiO2 in separate experiments. The antioxidants used were mannitol (4 mM final concentration), SOD (1000 Units final concentration) and nacystelin (500 μM final concentration). To test the specificity of the superoxide/SOD reaction, heat inactivated SOD (90°C for 5 minutes) was also added to the erythrocyte and particle mixture to give a final concentration of approximately 210 μg/ml (equivalent to 1000 Units SOD).

To investigate the role of transition metals in the haemolytic potential of the particles, the particles were incubated with deferoxamine mesylate (10 mM final concentration; Sigma, UK) for 2 hours in a shaking water bath at 37°C before exposure to erythrocytes.


All data are expressed as mean (SEM). The number of observations for each experiment was nine except where stated. The data were analysed by one way analysis of variance (ANOVA) with Tukey's multiple comparison test,and α<0.05 was considered significant for all comparisons.



All three respirable MVA samples possessed similar surface areas which were comparable with TiO2, but less than that of DQ12 (table 1).

Table 1

Physical characteristics of three respirable samples of Montserrat volcanic ash (M1, M2, and M3), DQ12 quartz, and TiO2

Analysis of the respirable MVA samples with XRD showed that they consisted mainly of plagioclase feldspar of roughly andesine composition. Within the context of these ash samples, the measurment of cristobalite by XRD proved difficult due to coincidence of the major plagioclase peak with that representing the cristobalite peak at 22.0°2θ. The cristobalite content of the MVA samples was assessed and corrected for plagioclase by measuring the peak intensity at two other plagioclase peaks (27.8°2θ and 82.1°2θ) and calculating the intensity at 22.0°2θ that could be attributed to plagioclase from tabulated ratios of the relative intensity of the three peaks in an ideal andesite sample. After correction, M2 was found to contain the largest percentage of cristobalite compared with M3 and M1 (table 1).

The size distribution of the three respirable MVA particle samples were comparable with each other with the largest percentage of particles by number in the range of 0.1 to 0.3 μm (fig 1). Within this size range, M1 was found to contain the largest percentage of particles at 29% compared with M3 at 21.9%, and M2 at 19%. The DQ12 and TiO2 contained 26.2% and 31.9% of particles in this range respectively. There was however a “tail” of larger particles in the three MVA samples which would be anticipated to impact on the surface area. However, as already noted, there was no marked differences in surface areas between the MVA samples, DQ12 and TiO2.

Figure 1

The proportional particle size distribution as assessed by transmission electron microscopy image analysis.


After treatment of the A549 cells for 24 hours, all of the particles tested induced a dose dependent decrease in MTT metabolism, reaching a maximal effect at 500 μg/ml (fig 2).

Figure 2

The effect of a 500 μg/ml dose of MVA samples, DQ12 and TiO2, in the presence or absence of the antioxidant mannitol (2 mM), on the metabolism of MTT by A549 cells after 24 hours. Results are expressed as a percentage of untreated cells. (*** p<0.001; M2 or M3 v DQ12 or TiO2.)

The TiO2 sample was found to be less cytotoxic than either the MVA samples or DQ12 compared with controls at the lower doses tested—for example, 125 μg/ml, p<0.001 (results expressed as MTT absorbance as a percentage of untreated cells); mean (SD) control=100% (4.61%); M1=72.25% (5.11%); M2=74.18% (5.76%); M3=72.29% (6.17%); DQ12=67.33% (4.93%); and TiO2=79.44% (5.19%). However, at higher doses tested there were no significant differences between any of the particles tested.

The effect of the antioxidant mannitol on the inhibition of A549 metabolic function by particles was also investigated. At 24 hours all of the particles tested in the presence of mannitol (2 mM) continued to induce a dose dependent decrease in metabolic reduction of MTT, compared with the control, again reaching a maximal effect at 500 μg/ml (fig 2). However, in the presence of mannitol, TiO2and DQ12 were significantly less cytotoxic than either M2 or M3 (500 μg/ml; p<0.001; fig 2). This was also reflected at the lowest concentration tested, 62.5 μg/ml, where only M2 and M3 were able to significantly decrease MTT metabolism compared with the controls (p<0.001 (results expressed as MTT absorbance as a percentage of untreated cells); mean (SD) control=79.29% (2.16%); M1=74.65% (5.08%); M2=63.13% (4.80%); M3=59.97% (2.00%); DQ12=68.19% (2.59%) and TiO2=73.63% (2.77%).

Similar results were also found at 48 hours (data not shown).


A dose dependent increase in erythrocyte haemolysis was found with all particle types tested (fig 3). The DQ12 had the greatest haemolytic ability (109% (1.5%) haemolysis at 30 mg/ml), with TiO2having the least (0.75% (0.5%) haemolysis at 30 mg/ml). The three MVA samples had a similar dose dependent increase in haemolysis which although lower than the DQ12 haemolysis, was significantly higher than TiO2 at both 20 and 30 mg/ml (p<0.001; fig3).

Figure 3

The effect of an increasing particle concentration of MVA samples, DQ12, and TiO2 on the haemolysis of sheep blood erythrocytes. Results are expressed as percentage haemolysis compared with both negative (0.9% sodium chloride solution) and positive (0.1% Triton X-100) controls. (***p<0.001; haemolysis induced by TiO2 v that induced by the MVA samples.)

The addition of 4 mM mannitol slightly decreased the haemolysis induced by all the MVA samples; however, this was only significant with M1 (p<0.001; fig 4).

Figure 4

Sheep blood erythrocyte haemolysis induced by 30 mg/ml concentration of particles in the presence or absence of 4 mM mannitol (*** p<0.001).

The SOD (1000 Units) induced the greatest inhibition of haemolysis found with any antioxidant tested (p<0.001; fig 5). To find whether these effects were due to the specific enzymatic activity of SOD or due to a protein coating effect, a solution of 1000 Units SOD (approximately 210 μg/ml) was heat inactivated, as described previously, and added to the reaction solutions. The heat inactivated SOD (HI-SOD) was also found to cause a significant inhibition of haemolysis induced by both M2 and M3 ash samples (p<0.001; fig 5), but not that induced by M1.

Figure 5

Sheep blood erythrocyte haemolysis induced by 30 mg/ml concentration of particles with the additions of 1000 Units SOD and 210 μg/ml heat inactivated SOD (HI-SOD). (*** p<0.001 haemolysis induced by the MVA samples only v that induced after the addition of either SOD or HI-SOD.)

The addition of 500 μM nacystelin did not cause a significant decrease in the haemolysis induced with any of the particles tested (table 2).

Table 2

Erythrocyte haemolysis induced by 30 mg/ml of particles in the prescence or absence of either 10 mM deferoxamine or 500 μM nacystelyn (results expressed as mean (SEM) percentage haemolysis by comparison with both negative (0.9% NaCl) and positive (Triton X-100) controls)

Also, chelation of metals by deferoxamine (10 mM) did not inhibit the haemolysis induced by any of the MVA samples (table 2). By contrast, deferoxamine seemed to increase the haemolytic ability of DQ12, but this was not found to be significant.


The reported health effects of volcanic ash vary between different volcanoes. For example, the prevalence of respiratory symptoms of exposed people inhabiting five towns around the crater of Mount Sakurajima in Japan were found to be minimal.23 Analysis of this ash showed a crystalline silica content which was almost negligible and that the major component of the ash particulate was non-respirable.24

By contrast, a fourfold increase in emergency room visits for patients with asthma and a twofold increase for patients with bronchitis followed the 1980 eruption of Mount St Helens in the United States.2 Analysis of this ash showed a crystalline silica content of between 3% and 7.2%5 6 25 of which 4.2% was cristobalite.5 6 The ash particulates were found to be around 90%26 and 99% respirable (defined as less than 10 μm in diameter in this study).6

In the present study collection of the MVA samples and their subsequent analysis showed that M2 (accumulated ash) contained 11.1% cristobalite, which was twofold greater than that of the M1 and M3 samples, and threefold greater than the pathogenic Mount St Helens ash.

The particle size distributions of the respirable MVA samples were comparable with each other, with M1 (the explosive ash sample) being slightly finer than M2 (the accumulated ash sample) or M3 (the ash sample from a single pyroclastic flow). As a consequence, the surface areas of the three samples were also found to be similar. These data correlated well with their haemolytic ability in that the three MVA samples all induced a dose dependent increase in haemolysis inducing between 36% and 44% haemolysis at the highest dose. These data further correlate well with those from ash particles from the Mount St Helens eruptions which were found to be significantly haemolytic and that the ash with the greatest surface area also possessed the greatest ability to induce haemolysis.16

The addition of 4 mM mannitol significantly decreased the haemolysis induced by the M1 sample, but not that induced by M2 or M3. However, in general, the effects of mannitol on the haemolysis induced by all three MVA ash samples was relatively small indicating that hydroxyl radical production did not play a major part in the haemolytic ability of these particles. Nacystelyn, a lysinated derivative of the glutathione precursor N-acetylcysteine, was also used as an antioxidant in the haemolysis assay. Nacystelyn did not decrease the haemolytic ability of any of the particles tested which again would suggest that free radical production was not a major component of the haemolytic potential of these particles, or that nacystelyn is unsuitable as an erythrocyte antioxidant within cells.

With the addition of 1000 Units SOD (approximately equivalent to 210 μg/ml), a significant decrease was found in the haemolytic ability of the MVA samples, but not with the pure silica sample of DQ12. These data correlate with those of a study by Razzaboniet al 22 where haemolysis induced by pure silica could not be decreased with a dose range of SOD from 10 to 300 μg/ml. From these results alone it would seem that most erythrocyte membrane damage caused by the ash samples was due to the production of superoxide. However, with such a large concentration of SOD and therefore protein, the decrease in haemolysis could have been due to the particle coating effect of the SOD protein. To find whether the decrease in haemolysis was due to either a specific dismutation of superoxide, or protein coating of particles, a non-specific enzyme with similar structure to SOD was sought. A bovine cathepsin B precursor was identified as having a similar molecular weight and tertiary structure to SOD, however, this is a protease and would therefore have been unsuitable for use in the haemolysis assay. Despite the limitations of heat inactivation—such as disruption of tertiary structure—a heat inactivated protein solution of SOD was used (HI-SOD). The haemolysis induced by M1 was inhibited by SOD, but not by HI-SOD suggesting that the decrease in haemolysis was in fact due to a specific dismutation of the superoxide radical produced by the M1 sample in the reaction solution. However, the haemolytic ability of M2 and M3 was significantly decreased with the addition of both SOD and HI-SOD. Subsequently these results suggested that the decrease in haemolytic ability found with M2 and M3 was due to protein coating of particles and not a specific dismutation of superoxide. Also, these results indicate differences in the mechanisms of the biological reactivity of these particles in accordance with their origin.

The role of particle surface metal ions in the haemolytic activity found for the MVA samples, DQ12, and TiO2 was investigated by addition of the metal ion chelator deferoxamine (10 mM). After a 2 hour preincubation of deferoxamine and particles, no significant decrease in haemolytic ability of the particles was found. This would imply that metal ions are not a major factor in the haemolytic activity or that the available metal ions present in the MVA samples were minimal.

It should be noted that the percentage haemolysis on exposure to the MVA samples in these latter experiments were lower than found in earlier parts of this study. Increased red cell fragility in aging erythrocytes is very likely to explain these results. These differences in observed haemolysis could also be due to using a percentage solution of sheep blood erythrocytes as opposed to a specific cell number.

In this study all of the MVA samples, DQ12, and TiO2induced a dose dependent decrease in the A549 metabolism of MTT which would suggest that the metabolic inhibition found was independent of particle composition. There was, however, significantly less toxicity caused by TiO2 than DQ12 at a lower dose. With the addition of the antioxidant mannitol, the cytotoxic effect induced by M1, DQ12, and TiO2 was significantly less. Inhibition by mannitol implies involvement of hydroxyl radicals and therefore in this in vitro mechanism M1 seems to have its effect through this reactive intermediate. The metabolic inhibition induced by the addition of M2 and M3 could not be reduced by the addition of mannitol. These differences in the MVA samples could possibly be related to the origin of the volcanic ash, of which M1 is the only ash sample derived from a purely explosive event.

In the MVA samples we have calculated a maximum cristobalite content of 11.1% in sample M2, which is most likely present within a complex mineral matrix containing elements—such as aluminium—which have the potential to reduce the reactivity of silica. We note that these cristobalite concentrations are slightly lower than the overall crystalline silica contents reported by Baxter et al (1999).1 Studies documenting the relation between silica haemolysis and cytotoxicity have, in general, used pure silica samples. With the interventions we have used in our experimental systems, significantly decreasing changes in reactivity were only found in the M1 ash sample. The M1 was derived from a single explosive event compared with M2 from predominantly pyroclastic flow sources, and M3 from a single pyroclastic flow. As pyroclastic flow ash is known to be physically and chemically different from explosive ash,1this may explain the in vitro differences between M1 compared with M2 and M3.

The haemolysis assays in this study were not used to understand the pathophysiology of the particles, as the large doses and inappropriate target cells preclude this, but solely to assess the surface reactivity of the mixed mineral ash samples in direct comparison with the pure silica sample of DQ12 and the relatively inert TiO2. With the haemolysis of sheep erythrocytes as a model, we consistently found that the ash samples had a surface reactivity lower than that of DQ12, however, in all experiments this surface reactivity was significantly greater than an equal surface area dose of TiO2. Erythrocyte membrane damage by the MVA samples was largely through a mechanism that did not involve oxidative stress, except for M1. The haemolytic effect of M1, after addition of SOD or HI-SOD, was complex in that it was SOD inhibitable—that is, driven by superoxide anions, but not reduced by the coating effect of HI-SOD.

In conclusion, the approach taken here was to use the highly pathogenic DQ12 quartz and the non-pathogenic dust TiO2 as benchmarks for the potential pathogenicity of the MVA samples. The three different MVA samples were of similar size and surface area to DQ12 and TiO2. All three ash samples were significantly more haemolytic than TiO2, but much less so than DQ12. Inhibitor studies are summarised in table 3 and show that there was some evidence for the involvement of superoxide anion in the haemolytic activity of some of the ash samples. From the benchmarking we anticipate that the MVA samples would have much less potential to cause lung injury than quartz but slightly more than TiO2 and that the origin of the MVA samples may determine differences in reactivity. Whether the increased activity of MVA compared with TiO2 is of sufficient magnitude to be detectable in a plausible in vivo exposure will only be answered by experiment. Further research into the toxicology of an increased range of Montserrat volcanic ash samples is warranted to ensure that representative material is assessed for toxicity.

Table 3

Summary of inhibitor studies with particles


We acknowledge the expert assistance of Dr Colin Mitchell. KD is the British Lung Foundation/Transco Fellow in air pollution and respiratory health.


View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.